Skip to content

Cocoa for cognitive function, mood and cardiovascular function: acute and cumulative effect in younger adults.

The acute and cumulative effect of high-flavanol cocoa vs placebo on cognitive function, mood and cardiovascular function in healthy adults aged 18-40 years: a randomised double-blind placebo-controlled one month trial

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12613000626763
Enrollment
40
Registered
2013-05-31
Start date
2013-08-19
Completion date
2015-10-30
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Study aims to investigate the effects of acute and cumulative doses of high-flavanol cocoa on cognitive function, mood, and cardiovascular health in a group of healthy younger adults.

Interventions

Participants will take one tablet of a cocoa supplement (containing 250 mg polyphenols) after baseline assessment & assessment 2 hours after ingestion (acute) and one tablet of cocoa supplement daily for 4 weeks (cumulative). Calendars including trial information will be provided to patients at baseline. To assess compliance, patients will be instructed to mark each day when they have taken the trial capsules, and bring the calendar and any remaining trial capsules to their next appointment.

Sponsors

National Institute of Integrative Medicine
Lead SponsorOther

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

Healthy between 18-40 years of age

Exclusion criteria

1. Poor comprehension of written and spoken English 2. Psychiatric disorder 3. Suffering from endocrine or gastrointestinal disorders 4. Pregnant or lactating 5. Taking antidepressants, antipsychotics, anxiolytics, illicit drugs or any cognitive enhancing drugs 6. Undergoing participation in another study 7. Suffer from colour blindness or any other severe visual impairment 8. Taking anti-coagulants or have bleeding disorders

Outcome results

None listed

Source: ANZCTR · Data processed: Mar 4, 2026